N-Boc-L-azetidine-2-carboxylic acid
CAS: 51077-14-6
Ref. 3D-FB18948
1g | A consultar | ||
2g | A consultar | ||
5g | A consultar | ||
10g | A consultar | ||
25g | A consultar |
Información del producto
- (2S)-1,2-Azetidinedicarboxylic acid
- 1-(1,1-dimethylethyl) ester(S)-1-(tert-Butoxycarbonyl)-azetidine-2-carboxylic acid1-(tert-But yloxycarbonyl)azetidine-2(S)-carboxylic acid1-Boc-L-azetidine-2-carboxylic acid
- (S)-N-tert-Butoxycarbonyl-azetidine-2-carboxylic acid
- (S)-N-BOC-Azetidine-2-carboxylic acid
- 1-Boc-L-azetidine-2-carboxylic acid
- (2S)-1-(tert-butoxycarbonyl)azetidine-2-carboxylic acid
- (2S)-1-(tert-butoxycarbonyl)azetidine-2-carboxylate
- (S)-1-Boc-2-azetidinecarboxylic acid
- (2S)-1-[(tert-butoxy)carbonyl]azetidine-2-carboxylic acid
N-Boc-L-azetidine-2-carboxylic acid is a drug that binds to the opioid receptor and has anorectic effects. The enzyme glutamic acid decarboxylase (GAD) catalyzes the conversion of glutamate to GABA, which is a major inhibitory neurotransmitter in the central nervous system. N-Boc-L-azetidine-2-carboxylic acid inhibits this enzyme, thereby increasing glutamate levels. This increased level of glutamate increases the release of dopamine, which leads to increased appetite suppression. N-Boc L-azetidine 2 carboxylic acid has been shown to have an anti-obesity effect in animal models. In addition, it has been found to be effective in reducing weight gain and improving metabolic profiles in humans with type 2 diabetes.
Propiedades químicas
Consulta técnica sobre: 3D-FB18948 N-Boc-L-azetidine-2-carboxylic acid
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.